Resveratrol suppresses the STAT3 signaling pathway and inhibits proliferation of high glucose-exposed HepG2 cells partly through SIRT1

Li,Yongguang; Zhu,Wei; Li,Jingbo; Liu,Mingya; Wei,Meng

doi:10.3892/or.2013.2748

Resveratrol suppresses the STAT3 signaling pathway and inhibits proliferation of high glucose-exposed HepG2 cells partly through SIRT1

Authors:
- Yongguang Li
- Wei Zhu
- Jingbo Li
- Mingya Liu
- Meng Wei
View Affiliations

Affiliations: Department of Cardiology, Sixth Hospital, Shanghai Jiao Tong University, State Key Discipline of Cardiology, Shanghai 200233, P.R. China
Published online on: September 20, 2013 https://doi.org/10.3892/or.2013.2748
Pages: 2820-2828

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hepatocellular carcinoma is the most common type of liver cancer. The risk of hepatocellular carcinoma for type 2 diabetic patients is greater than that for non-diabetic individuals although the mechanism is unclear. The cancer suppressor resveratrol inhibits cancer cell proliferation partly through the STAT3 signaling pathway. However, the effects of resveratrol on STAT3 in high glucose-exposed HepG2 cells and the role of SIRT1 are not clear to date. The aim of the present study was to investigate the effects of resveratrol on STAT3 and SIRT1 regarding the proliferation of high glucose-exposed HepG2 cells. HepG2 cells were cultured in DMEM containing glucose (2.8, 5.5 and 25 mM) and resveratrol (0, 10 and 100 µM). HepG2 cell proliferation and viability were analyzed by MTT assays. The levels of p-STAT3 and SIRT1 were analyzed by western blotting, and RT-PCR methods were used to detect the transcription levels of cyclin B1, cyclin D1, VEGF and MMP-9. SIRT1-specific short-interfering RNA was used to investigate the role of SIRT1 in p-STAT3 signaling. A high glucose concentration (25 mM) induced HepG2 cell proliferation. This effect was suppressed by resveratrol (100 µM), and the effect on the p-STAT3 signaling pathway was found to be SIRT1-dependent. Our findings may provide new insights into the mechanism by which resveratrol suppresses HepG2 cell proliferation under conditions of high glucose. Furthermore, this information may provide the basis for a novel therapeutic strategy for hepatocellular carcinoma patients suffering from either diabetes or hyperglycemia.

View Figures

View References

1	El-Serag HB, Hampel H and Javadi F: The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol. 4:369–380. 2006. View Article : Google Scholar : PubMed/NCBI
2	Zheng M, Chen R, Zhong H, et al: Side-effects of resveratrol in HepG2 cells: reduced pten and increased bcl-xl mRNA expression. Mol Med Rep. 6:1367–1370. 2012.PubMed/NCBI
3	Bhardwaj A, Sethi G, Vadhan-Raj S, et al: Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-κB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood. 109:2293–2302. 2007.PubMed/NCBI
4	Capiralla H, Vingtdeux V, Venkatesh J, et al: Identification of potent small-molecule inhibitors of STAT3 with anti-inflammatory properties in RAW 264.7 macrophages. FEBS J. 279:3791–3799. 2012. View Article : Google Scholar : PubMed/NCBI
5	Haghikia A, Stapel B, Hoch M and Hilfiker-Kleiner D: STAT3 and cardiac remodeling. Heart Fail Rev. 16:35–47. 2011. View Article : Google Scholar
6	Wen S, Li H, Wu ML, et al: Inhibition of NF-κB signaling commits resveratrol-treated medulloblastoma cells to apoptosis without neuronal differentiation. J Neurooncol. 104:169–177. 2011.
7	Cho IR, Koh SS, Malilas W, et al: SIRT1 inhibits proliferation of pancreatic cancer cells expressing pancreatic adenocarcinoma up-regulated factor (PAUF), a novel oncogene, by suppression of β-catenin. Biochem Biophys Res Commun. 423:270–275. 2012.PubMed/NCBI
8	Kim YJ, Hwang SH, Lee SY, et al: miR-486-5p induces replicative senescence of human adipose tissue-derived mesenchymal stem cells and its expression is controlled by high glucose. Stem Cells Dev. 21:1749–1760. 2012. View Article : Google Scholar : PubMed/NCBI
9	Nie Y, Erion DM, Yuan Z, et al: STAT3 inhibition of gluconeogenesis is downregulated by SirT1. Nat Cell Biol. 11:492–500. 2009. View Article : Google Scholar : PubMed/NCBI
10	Li T, Wang W, Chen H, Li T and Ye L: Evaluation of anti-leukemia effect of resveratrol by modulating STAT3 signaling. Int Immunopharmacol. 10:18–25. 2010. View Article : Google Scholar : PubMed/NCBI
11	Pawlus MR, Wang L and Hu CJ: STAT3 and HIF1alpha cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells. Oncogene. Apr 22–2013.(Epub ahead of print).
12	Li J, Cui G, Sun L, et al: STAT3 acetylation-induced promoter methylation is associated with downregulation of the ARHI tumor-suppressor gene in ovarian cancer. Oncol Rep. 30:165–170. 2013.PubMed/NCBI
13	Absood A, Hu B, Bassily N and Colletti L: VIP inhibits human HepG2 cell proliferation in vitro. Regul Pept. 146:285–292. 2008. View Article : Google Scholar : PubMed/NCBI
14	Baur JA and Sinclair DA: Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 5:493–506. 2006. View Article : Google Scholar : PubMed/NCBI
15	Athar M, Back JH, Tang X, et al: Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol. 224:274–283. 2007. View Article : Google Scholar : PubMed/NCBI
16	Kotha A, Sekharam M, Cilenti L, et al: Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein. Mol Cancer Ther. 5:621–629. 2006. View Article : Google Scholar : PubMed/NCBI
17	Yu LJ, Wu ML, Li H, et al: Inhibition of STAT3 expression and signaling in resveratrol-differentiated medulloblastoma cells. Neoplasia. 10:736–744. 2008.PubMed/NCBI
18	Giraud AS, Menheniott TR and Judd LM: Targeting STAT3 in gastric cancer. Expert Opin Ther Targets. 16:889–901. 2012. View Article : Google Scholar : PubMed/NCBI
19	Deng J, Liu Y, Lee H, et al: S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites. Cancer Cell. 21:642–654. 2012. View Article : Google Scholar : PubMed/NCBI
20	Tkach M, Coria L, Rosemblit C, et al: Targeting Stat3 induces senescence in tumor cells and elicits prophylactic and therapeutic immune responses against breast cancer growth mediated by NK cells and CD4⁺ T cells. J Immunol. 189:1162–1172. 2012. View Article : Google Scholar : PubMed/NCBI
21	Sen M, Joyce S, Panahandeh M, et al: Targeting Stat3 abrogates EGFR inhibitor resistance in cancer. Clin Cancer Res. 18:4986–4996. 2012. View Article : Google Scholar : PubMed/NCBI
22	Yang CL, Liu YY, Ma YG, et al: Curcumin blocks small cell lung cancer cell migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway. PLoS One. 7:e379602012. View Article : Google Scholar : PubMed/NCBI
23	Frye RA: Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem Biophys Res Commun. 273:793–798. 2000. View Article : Google Scholar : PubMed/NCBI
24	Chang KT and Min KT: Regulation of lifespan by histone deacetylase. Ageing Res Rev. 1:313–326. 2002. View Article : Google Scholar : PubMed/NCBI
25	Sestito R, Madonna S, Scarponi C, et al: STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation. FASEB J. 25:916–927. 2011. View Article : Google Scholar : PubMed/NCBI
26	Bernier M, Paul RK, Martin-Montalvo A, et al: Negative regulation of STAT3 protein-mediated cellular respiration by SIRT1 protein. J Biol Chem. 286:19270–19279. 2011. View Article : Google Scholar : PubMed/NCBI
27	Chen X, Cao Y, Lv D, Zhu Z, Zhang J and Chai Y: Comprehensive two-dimensional HepG2/cell membrane chromatography/monolithic column/time-of-flight mass spectrometry system for screening anti-tumor components from herbal medicines. J Chromatogr A. 1242:67–74. 2012. View Article : Google Scholar